In conclusion, we confirmed for the first time that the TSC-Exos could reduce mitochondrial fission and ROS production of cardiomyocytes by increasing the expression of Mfn2 to reduce Dox-induced cardiomyocyte apoptosis and improve cardiac function, which provides a potential new treatment scheme for the treatment of heart failure. Here, MFN2 is linked to heart failure.